Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trading of pharmaceuticals in China and internationally. The company offers pharmaceutical products for blood and hematopoietic, antineoplastic and immunomodulatory, respiratory, anti-inflammatory and analgesic, and chronic diseases, as well as mineral supplements, Chinese medicines, and antibiotics. It offers its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. The company is based in Harbin, China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.44572960011284296 | N/A |
Market Cap | $1.12B | N/A |
Shares Outstanding | 2.52B | N/A |
Employees | 10.06K | N/A |